ENSILICATED TECHNOLOGIES LTD
Company number 13537400 · Monitor this company
Executive summary
Ensilicated Technologies Ltd is an early-stage biotechnology company with solid net current assets and cash reserves but increasing short-term liabilities and widening losses. The company’s ongoing viability depends on continued investor support amid typical start-up operating losses. No regulatory compliance issues are evident, but investor due diligence should focus on liquidity management and funding sustainability.
Shareholders' funds
£5,375,746
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-07-29
- Employees
- 10 (2025 accounts · was 9 in 2025)
- Registered office
- Science Creates St Philips Albert Road, St. Philips, Bristol, England, BS2 0XJ
- Postcode
- BS2 0XJ
- Capital
- 225 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-07-28
- Next due by
- 2027-08-11
Nature of business (SIC)
- 21200 Manufacture of pharmaceutical preparations
- 71200 Technical testing and analysis
- 72110 Research and experimental development on biotechnology
- 72190 Other research and experimental development on natural sciences and engineering
Officers 9 current · 4 resigned
Data protection registration
Registered with the ICO as a data protection fee payer — ZB909331 (Tier 1), registered since 2025.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- ensilicated.com
- Phone
- 0122754524, 0553876185, 095566385
EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals.
Among its peers
Top 25%
by shareholders' funds, of 9 similar companies in BS — measured against the wider sector
Among the biggest employers among its local peers (10 staff).
Trading since 2021.